| DESCRIPTION | - ARTHUR OSOL, Remington's Pharmaceutical Sciences 15th edition, MACK PUBLISHING, pages 1035 - 1038,157 | - |
| DESCRIPTION | - COLE ET AL., Monoclonal Antibodies and Cancer Therapy, ALAN R. LISS, INC., (1985), pages 77 - 96 | - |
| DESCRIPTION | - CONNOLLY DC; BAO R; NIKITIN AY; STEPHENS KC; POOLE TW; HUA X; HARRIS SS; VANDERHYDEN BC; HAMILTON TC, "Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer", CANCER RES, (20030315), vol. 63, no. 6, pages 1389 - 97 | - |
| DESCRIPTION | - KOHLER G., M. C, NATURE, (1975), vol. 256, pages 495 - 497 | - |
| DESCRIPTION | - MIZUKAMI T; ITOH S, "A new SV40-based vector developed for cDNA expression in animal cells", J BIOCHEM (TOKYO, (198705), vol. 101, no. 5, pages 1307 - 10 | - |
| DESCRIPTION | - MORRISON SL; JOHNSON MJ; HERZENBERG LA; OI VT., "Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains", PROC NATL ACAD SCI USA., (198411), vol. 81, no. 21, pages 6851 - 5 | - |
| DESCRIPTION | - O'HARE K; BENOIST C; BREATHNACH R, "Transformation of mouse fibroblasts to methotrexate resistance by a recombinant plasmid expressing a prokaryotic dihydrofolate reductase", PROC NATL ACAD SCI USA., (198103), vol. 78, no. 3, pages 1527 - 31, XP055347309 | - |
| DESCRIPTION | - ROGUSKA MA; PEDERSEN JT; KEDDY CA; HENRY AH; SEARLE SJ; LAMBERT JM; GOLDMACHER VS; BLATTLER WA; REES AR; GUILD BC., "Humanization of murine monoclonal antibodies through variable domain resurfacing", PROC NATL ACAD SCI USA., (19940201), vol. 91, no. 3, pages 969 - 73 | - |
| DESCRIPTION | - SHOPES B, "A genetically engineered human IgG mutant with enhanced cytolytic activity", J IMMUNOL., (19920501), vol. 148, no. 9, pages 2918 - 22 | - |
| DESCRIPTION | - THOTAKURA NR; BAHL OP, "Enzymatic deglycosylation of glycoproteins", METHODS ENZYMOL., (1987), vol. 138, pages 350 - 9 | - |
| DESCRIPTION | - MIYAJI H; MIZUKAMI T; HOSOI S; SATO S; FUJIYOSHI N; ITOH S, "Expression of human beta-interferon in Namalwa KJM-1 which was adapted to serum-free medium", CYTOTECHNOLOGY, (199003), vol. 3, no. 2, doi:doi:10.1007/BF00143675, pages 133 - 40, XP002904455 | |
| DESCRIPTION | - EDGE AS; FALTYNEK CR; HOF L; REICHERT LE JR; WEBER P., "Deglycosylation of glycoproteins by trifluoromethanesulfonic acid", ANAL BIOCHEM., (19811115), vol. 118, no. 1, doi:doi:10.1016/0003-2697(81)90168-8, pages 131 - 7, XP024817134 | |
| DESCRIPTION | - KUWANA Y; ASAKURA Y; UTSUNOMIYA N; NAKANISHI M; ARATA Y; ITOH S; NAGASE F; KUROSAWA Y, "Expression of chimeric receptor composed of immunoglobulin-derived V regions and T-cell receptor-derived C regions", BIOCHEM BIOPHYS RES COMMUN., (19871231), vol. 149, no. 3, doi:doi:10.1016/0006-291X(87)90502-X, pages 960 - 8, XP024836482 | |
| DESCRIPTION | - SHITARA K; NAKAMURA K; TOKUTAKE-TANAKA Y; FUKUSHIMA M; HANAI N., "A new vector for the high level expression of chimeric antibodies in myeloma cells", J IMMUNOL METHODS, (19940103), vol. 167, no. 1-2, doi:doi:10.1016/0022-1759(94)90096-5, pages 271 - 8, XP023974389 | |
| DESCRIPTION | - GILLIES SD; MORRISON SL; OI VT; TONEGAWA S., "A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene", CELL, (198307), vol. 33, no. 3, doi:doi:10.1016/0092-8674(83)90014-4, pages 717 - 28, XP027462707 | |
| DESCRIPTION | - PADLAN EA, "A possible procedure for reducing the immunogenicity of antibody variable domains while preserving their ligand-binding properties", MOL IMMUNOL., (199104), vol. 28, no. 4-5, doi:doi:10.1016/0161-5890(91)90163-E, pages 489 - 98, XP023795271 | |
| DESCRIPTION | - BRADY G; JANTZEN HM; BERNARD HU; BROWN R; SCHUTZ G; HASHIMOTO-GOTOH T., "New cosmid vectors developed for eukaryotic DNA cloning", GENE, (198402), vol. 27, no. 2, doi:doi:10.1016/0378-1119(84)90143-4, pages 223 - 32, XP023539469 | |
| DESCRIPTION | - CHARDES T; VILLARD S; FERRIERES G; PIECHACZYK M; CERUTTI M; DEVAUCHELLE G; PAU B, "Efficient amplification and direct sequencing of mouse variable regions from any immunoglobulin gene family", FEBS LETT., (19990611), vol. 452, no. 3, doi:doi:10.1016/S0014-5793(99)00649-3, pages 386 - 94, XP004259787 | |
| DESCRIPTION | - GAZZANO-SANTORO H; RALPH P; RYSKAMP TC; CHEN AB; MUKKU VR, "A nonradioactive complement-dependent cytotoxicity assay for anti-CD20 monoclonal antibody", J IMMUNOL METHODS, (19970328), vol. 202, no. 2, doi:doi:10.1016/S0022-1759(97)00002-1, pages 163 - 71, XP004126276 | |
| DESCRIPTION | - MASON JO; WILLIAMS GT; NEUBERGER MS, "Transcription cell type specificity is conferred by an immunoglobulin VH gene promoter that includes a functional consensus sequence", CELL, (198506), vol. 41, no. 2, doi:doi:10.1016/S0092-8674(85)80021-0, pages 479 - 87, XP023913259 | |
| DESCRIPTION | - NEUBERGER MS; WILLIAMS GT; FOX RO, "Recombinant antibodies possessing novel effector functions", NATURE, (19841213), vol. 312, no. 5995, doi:doi:10.1038/312604a0, pages 604 - 8, XP000650347 | |
| DESCRIPTION | - RIECHMANN L; CLARK M; WALDMANN H; WINTER G, "Reshaping human antibodies for therapy", NATURE, (19880324), vol. 332, no. 6162, doi:doi:10.1038/332323a0, pages 323 - 7, XP000020414 | |
| DESCRIPTION | - BLUESTONE, J. A.; ABBAS, A. K., "Natural versus adaptive regulatory T cells", NATURE REV. IMMUNOL., (2003), vol. 3, doi:doi:10.1038/nri1032, pages 253 - 257, XP009071268 | |
| DESCRIPTION | - BLUESTONE, J. A; ABBAS, A. K, "Natural versus adaptive regulatory T cells", NATURE REV. IMMUNOL., (2003), vol. 3, doi:doi:10.1038/nri1032, pages 253 - 257, XP009071268 | |
| DESCRIPTION | - URLAUB G; CHASIN LA, "Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity", PROC NATL ACAD SCI USA., (198007), vol. 77, no. 7, doi:doi:10.1073/pnas.77.7.4216, pages 4216 - 20, XP008004784 | |
| DESCRIPTION | - COTE RJ; MORRISSEY DM; HOUGHTON AN; BEATTIE EJ JR; OETTGEN HF; OLD LJ., "Generation of human monoclonal antibodies reactive with cellular antigens", PROC NATL ACAD SCI USA., (198304), vol. 80, no. 7, doi:doi:10.1073/pnas.80.7.2026, pages 2026 - 30, XP000650373 | |
| DESCRIPTION | - CARON PC; LAIRD W; CO MS; AVDALOVIC NM; QUEEN C; SCHEINBERG DA, "Engineered humanized dimeric forms of IgG are more effective antibodies", J EXP MED., (19921001), vol. 176, no. 4, doi:doi:10.1084/jem.176.4.1191, pages 1191 - 5, XP000914982 | |
| DESCRIPTION | - DEAGLIO S; DWYER KM; GAO W; FRIEDMAN D; USHEVA A; ERAT A; CHEN JF; ENJYOJI K; LINDEN J; OUKKA M, "Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression", J EXP MED., (20070514), vol. 204, no. 6, doi:doi:10.1084/jem.20062512, pages 1257 - 65, XP002485581 | |
| DESCRIPTION | - STROHAL R; KROEMER G; WICK G; KOFLER R, "Complete variable region sequence of a nonfunctionally rearranged kappa light chain transcribed in the nonsecretor P3-X63-Ag8.653 myeloma cell line", NUCLEIC ACIDS RES., (19870325), vol. 15, no. 6, doi:doi:10.1093/nar/15.6.2771, page 2771, XP001245639 | |
| DESCRIPTION | - STUDNICKA GM; SOARES S; BETTER M; WILLIAMS RE; NADELL R; HORWITZ AH, "Human-engineered monoclonal antibodies retain full specific binding activity by preserving non-CDR complementarity-modulating residues", PROTEIN ENG., (199406), vol. 7, no. 6, doi:doi:10.1093/protein/7.6.805, pages 805 - 14, XP009166823 | |
| EXAMINATION | - Sfm Hausler ET AL, "CD39 wird von humanen Ovarialkarzinomzelllinien exprimiert und hemmt die immunologische Tumorabwehr /Abstract/", Thieme E-Journals- Geburtshilfe Frauenheilkunde, (20080101), URL: https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0028-1089305, (20190604), XP055593991 | - |
| EXAMINATION | - David W Hoskin ET AL, "Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review)", International journal of oncology, GR, (20080101), vol. 32, doi:10.3892/ijo.32.3.527, ISSN 1019-6439, pages 527 - 535, XP055574827 | |
| OPPOSITION | - Anonymous, "Purified anti-human CD39 Antibody", BioLegend, (20171002), pages 1 - 3, XP055940755 | - |
| OPPOSITION | - Anonymous, "Purified anti-human CD39 Antibody", Biolegend - Data sheet, (20171002), pages 1 - 3, URL: https://www.biolegend.com/en-us/products/purified-anti-human-cd39-antibody-4361?GroupID=BLG5462, XP055825371 | - |
| OPPOSITION | - BLAY, J. et al., "The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine", Cancer Res., (19970000), vol. 57, no. 13, pages 2602 - 2605, XP055940997 | - |
| OPPOSITION | - BROWN, J.A. et al., "Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production", J Immunol., (20030000), vol. 170, no. 3, pages 1257 - 1266, XP002973918 | - |
| OPPOSITION | - DEAGLIO, S. et al., "Adenosine generation catalyzed by CD 39 and CD 73 expressed on regulatory T cells mediates immune expres- sion", Journal of Experimental Medicine, (20070000), vol. 204, no. 6, pages 1257 - 1265 | - |
| OPPOSITION | - DZHANDZHUGAZYAN, K.N. et al., "Ecto-ATP diphosphohydro-lase/ CD 39 is overexpressed in differentiated human melanomas", FEBS Lett., (19980000), vol. 430, no. 3, pages 227 - 230, XP055940972 | - |
| OPPOSITION | - GERSHON, R.K. et al., "Infectious immunological tolerance", Immunology, (19710000), vol. 21, pages 903 - 914, XP055941186 | - |
| OPPOSITION | - GOUTTEFANGEAS, C. et al., "Biochemical analysis and epitope map- ping of mAb defining CD 39", Leucocyte Typing, New York : Oxford, (19950000), pages 383 - 385, XP055940813 | - |
| OPPOSITION | - GOUTTEFANGEAS et al., "Biochemical analysis and epitope mapping of mAb defining CD 39", Leucocyte Typing V ; White Cell Differentiation Antigens; Proceedings of the 5th International Workshop, Boston, (19951103), pages 383 - 385, XP055574782 | - |
| OPPOSITION | - HÄUSLER et al., "CD39 is expressed by human ovarian carcinoma cell lines and inhibits immunological tumour defence", Geburtshilfe Frauenheilkunde, (20080000), page 68, XP055825357 | - |
| OPPOSITION | - HAUSLER et al., "CD 39 wird von humanen varialkarzinomzellinien exprimiert und hemmt die immunologishe Tumorabwehr", Geburtsiiilfe Frauenheilkd, (2008), vol. 68, page S178, XP055940708 | - |
| OPPOSITION | - HÄUSLER, S.F.M. et al., "Anti-CD 39 and anti- CD 73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking aden- osine-dependent immune evasion", Am J Transl Res, (20140000), vol. 6, no. 2, pages 129 - 139, XP055940990 | - |
| OPPOSITION | - HAUSLER, S.F.M. et al., "CD 39 wird von humanen Ovarialkar- zinomzellinien exprimiert und hemmt die immunologische Tumo- rabwehr", Thieme E-Journals- Geburtshilfe Frauenheilkunde, (20080000), pages 1 - 2, XP055593991 | - |
| OPPOSITION | - Häusler Sfm, Hönig A, Engel Jb, Krockenberger M, Wischhusen J, Dietl J, "CD39 wird von humanen Ovarialkarzinomzelllinien exprimiert und hemmt die immunologische Tumorabwehr", Thieme E-Journals- Geburtshilfe Frauenheilkunde, vol. 68, no. S01, (20080000), pages 1 - 2, URL: https://www.thieme- connect.de/products/ejournals/abstract/10.1055/s-0028-1 089305, XP055593991 | - |
| OPPOSITION | - HUANG, S. et al., "Role of A2a Extracellular Adenosine Receptor- Mediated Signaling in Adenosine-Mediated Inhibition of T- Cell Acti- vation and Expansion", Blood, (19970000), vol. 90, no. 4, pages 1600 - 1610, XP055941171 | - |
| OPPOSITION | - KANSAS, G.S. et al., "Expression, distribution, and biochemistry of human CD 39. Role in activation-associated homotypic adhesion of lymphocytes", J Immunol., (19910000), vol. 146, no. 7, pages 2235 - 44, XP002008569 | - |
| OPPOSITION | - Knutson Keith L., Dang Yushe, Lu Hailing, Lukas Jason, Almand Bond, Gad Ekram, Azeke Ehizoje, Disis Mary L., "IL-2 Immunotoxin Therapy Modulates Tumor-Associated Regulatory T Cells and Leads to Lasting Immune-Mediated Rejection of Breast Cancers in neu -Transgenic Mice", The Journal of Immunology, (20060000), vol. 177, no. 1, pages 84 - 91, XP002457766 | - |
| OPPOSITION | - Sfm Hausler, A.Honig, Jb Engel, M Krockenberger, J Wischhusen, J Dietl, "CD39 wird von humanen Ovarialkarzinomzelllinien exprimiert und hemmt die immunologische Tumorabwehr /Abstract/", Thieme E-Journals- Geburtshilfe Frauenheilkunde, (20080101), Thieme E-Journals- Geburtshilfe Frauenheilkunde, URL: https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0028-1089305, (20190604), XP055593991 | - |
| OPPOSITION | - SPYCHALA, J., "Tumor-promoting functions of adenosine", Pharmacol Ther., (20000000), vol. 87, no. 2-3, pages 161 - 173, XP055941182 | - |
| OPPOSITION | - Schetinger Maria, Morsch Vera Maria, Bonan Carla Denise, Wyse Angela, "NTPDase and 5'-nucleotidase activities in physiological and disease conditions: New perspectives for human health", BIOFACTORS, (20070000), vol. 31, no. 2, pages 77 - 98, XP009116149 | |
| OPPOSITION | - Schetinger Maria Rosa C; Morsch Vera Maria; Bonan Carla Denise; Wyse Angela T S, "NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health.", BIOFACTORS., OXFORD UNIVERSITY PRESS, OXFORD., GB, GB, (20070101), vol. 31, no. 2, doi:10.1002/biof.5520310205, ISSN 0951-6433, pages 77 - 98, XP009116149 | |
| OPPOSITION | - Gouttefangeas Cécile, Mansur Indra, Schmid Michel, Dastot Hélène, Gélin Catherine, Mahouy Guy, Boumsell Laurence, Bensussan Armand, "The CD39 molecule defines distinct cytotoxic subsets within alloactivated human CD8-positive cells", Eur. J. Immunol., (19920000), vol. 22, no. 10, pages 2681 - 2685, XP055941194 | |
| OPPOSITION | - AIELLO A ET AL, "Expression of differentiation and adhesion molecules in sporadic Burkitt's lymphoma.", HEMATOLOGICAL ONCOLOGY, WILEY, CHICHESTER, US, US, (19900701), vol. 8, no. 4, doi:10.1002/hon.2900080407, ISSN 0278-0232, pages 229 - 238, XP002516044 | |
| OPPOSITION | - SHI et al., "Prevalence of the Mercurial-Sensitive EctoATPase in Human Small Cell Lung Carcinoma: Characterization and Partial Purification", Archives of Biochemistry and Biophysics, (19940000), vol. 315, no. 1, doi:10.1006/abbi.1994.1487, pages 77 - 184, XP024752537 | |
| OPPOSITION | - Simon C. Robson ; Jean Sévigny ; Herbert Zimmermann, "The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance", Purinergic Signalling, Kluwer Academic Publishers, Do, Do, (20060530), vol. 2, no. 2, doi:10.1007/s11302-006-9003-5, ISSN 1573-9546, pages 409 - 430, XP019410894 | |
| OPPOSITION | - DWAER K M, ET AL., "CD39 and control of cellular immune responses", PURINERGIC SIGNALLING, SPRINGER VERLAG,, DE, DE, (20070206), vol. 3, doi:10.1007/s11302-006-9050-y, ISSN 1573-9538, pages 171 - 180, XP002485580 | |
| OPPOSITION | - DWYER et al., "CD 39 and control of cellular immune responses", PURINERGIC SIGNALLING, (20070206), vol. 3, doi:10.1007/s11302-006-9050-y, pages 171 - 180, XP019485439 | |
| OPPOSITION | - DWYER, K.M. et al., "CD 39 and control of cellular immune re- sponses", Purinergic Signalling, (20070000), vol. 3, doi:10.1007/s11302-006-9050-y, pages 171 - 180, XP019485439 | |
| OPPOSITION | - MOLLER SINA et al., "Monitoring the expression of purinoceptors and nucleotide-metabolizing ecto-enzymes with antibodies directed against proteins in native conformation", PURINERGIC SIGNALLING SEP 2007, (20070900), vol. 3, no. 4, doi:10.1007/s11302-007-9084-9, pages 359 - 366, XP019558228 | |
| OPPOSITION | - Sina Möller ; Caroline Jung ; Sahil Adriouch ; Gudrun Dubberke ; Fabienne Seyfried ; Michel Seman ; Friedrich Haag ; Friedrich Koch-Nolte, "Monitoring the expression of purinoceptors and nucleotide-metabolizing ecto-enzymes with antibodies directed against proteins in native conformation", Purinergic Signalling, Kluwer Academic Publishers, Do, Do, (20071006), vol. 3, no. 4, doi:10.1007/s11302-007-9084-9, ISSN 1573-9546, pages 359 - 366, XP019558228 | |
| OPPOSITION | - Knowles, A.F. ; Isler, R.E. ; Reece, J.F., "The common occurrence of ATP diphosphohydrolase in mammalian plasma membranes", BBA - Biomembranes Acta, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (19830526), vol. 731, no. 1, doi:10.1016/0005-2736(83)90401-7, ISSN 0005-2736, pages 88 - 96, XP023362457 | |
| OPPOSITION | - GOETTEL, J.A. et al., "AHR Activation Is Protective against Colitis Driven by T Cells in Humanized Mice", Cell Rep, (20160000), vol. 17, no. 5, doi:10.1016/j.celrep.2016.09.082, pages 1318 - 1329, XP055785340 | |
| OPPOSITION | - Wang, H.Y. Wang, R.F., "Regulatory T cells and cancer", Current Opinion in Immunology, (20070215), vol. 19, pages 217 - 223, XP005917723 | |
| OPPOSITION | - DZHANDZHUGAZYAN et al., "Ecto-ATP diphosphohydrolase / CD 39 is overexpressed in differentiated human melanomas", FEBS LETTERS, (19980000), vol. 430, no. 3, doi:10.1016/S0014-5793(98)00603-6, pages 227 - 230, XP004258065 | |
| OPPOSITION | - DZHANDZHUGAZYAN KARINE N , KIRKIN ALEXEI F, STRATEN PER THOR, ZEUTHEN JESPER, "Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas", FEBS Letters, ELSEVIER, AMSTERDAM., NL, NL, (19980703), vol. 430, no. 3, doi:10.1016/S0014-5793(98)00603-6, ISSN 0014-5793, pages 227 - 230, XP002668791 | |
| OPPOSITION | - M Sitkovsky, D Lukashev, S Deaglio, K Dwyer, S C Robson, A Ohta, "Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells", BRITISH JOURNAL OF PHARMACOLOGY, Wiley-Blackwell, UK, UK, (20080329), vol. 153, no. S1, doi:10.1038/bjp.2008.23, ISSN 0007-1188, pages S457 - S464, XP055248920 | |
| OPPOSITION | - SITKOVSKY et al., "Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells", British Journal of Pharmacology, (20080000), vol. 153, doi:10.1038/bjp.2008.23, pages S457 - S464, XP055248920 | |
| OPPOSITION | - Sitkovsky M, Lukashev D, Deaglio S, Dwyer K, Robson S C, Ohta A, "Adenosine A2A receptor antagonists: block- ade of adenosinergic effects and T regulatory cells", Brit J Phar- macol, (20080000), vol. 153, pages S457 - S464, XP071136473 | |
| OPPOSITION | - CURIEL, T. et al., "Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival", Nat Med, (20040000), vol. 10, no. 9, doi:10.1038/nm1093, pages 942 - 949, XP002523105 | |
| OPPOSITION | - Mario P. Colombo, Silvia Piconese, "Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy", Nature Reviews Cancer, (20071100), vol. 7, no. 11, pages 881 - 887, XP055487120 | |
| OPPOSITION | - Mario P. Colombo, Silvia Piconese, "Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy", Nature Reviews Cancer, Nature Pub. Group, London, London, (20071101), vol. 7, no. 11, doi:10.1038/nrc2250, ISSN 1474-175X, pages 880 - 887, XP055487120 | |
| OPPOSITION | - Moesta Achim K.; Li Xian-Yang; Smyth Mark J., "Targeting CD39 in cancer", NATURE REVIEWS IMMUNOLOGY, Nature Pub. Group, GB, GB, (19000101), vol. 20, no. 12, doi:10.1038/s41577-020-0376-4, ISSN 1474-1733, pages 739 - 755, XP037305549 | |
| OPPOSITION | - B B Fredholm, "Adenosine, an endogenous distress signal, modulates tissue damage and repair", Cell Death & Differentiation, Nature Publishing Group, GB, GB, (20070701), vol. 14, no. 7, doi:10.1038/sj.cdd.4402132, ISSN 1350-9047, pages 1315 - 1323, XP055574878 | |
| OPPOSITION | - KNOWLES, A. F. et al., "Inhibition of an ecto-ATP-diphosphohydrolase by azide", Eur J Biochem, (19990600), vol. 262, no. 2, pages 349 - 357, XP055825363 | |
| OPPOSITION | - Knowles Aileen F., Nagy Agnes K., "Inhibition of an ecto-ATP- diphosphohydrolase by azide", Eur J Biochem, (19990000), vol. 262, pages 349 - 357, XP055825363 | |
| OPPOSITION | - Akio Ohta, Elieser Gorelik, Simon J. Prasad, Franca Ronchese, Dmitriy Lukashev, Michael K. K. Wong, Xiaojun Huang, Sheila Caldwell, Kebin Liu, Patrick Smith, Jiang-Fan Chen, Edwin K. Jackson, Sergey Apasov, Scott Abrams, and Michail Sitkovsky, "A2A adenosine receptor protects tumors from antitumor T cells", Proceedings of the National Academy of Sciences, National Academy of Sciences, US, US, (20060829), vol. 103, no. 35, doi:10.1073/pnas.0605251103, ISSN 0027-8424, pages 13132 - 13137, XP007915452 | |
| OPPOSITION | - OHTA, A. et al., "A 2A adenosine receptor protects tumors from an- titumor T cells", Proc Natl Acad Sci U S A., (20060000), vol. 103, no. 35, doi:10.1073/pnas.0605251103, pages 13132 - 13137, XP007915452 | |
| OPPOSITION | - HODI, F.S. et al., "Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients", Proc Natl Acad Sci U S A., (20030000), vol. 100, no. 8, pages 4712 - 4717, XP008065659 | |
| OPPOSITION | - BENSUSSAN, A. et al., "Detection of membrane-bound HLA-G translated products with a specific monoclonal antibody", Proc Natl Acad Sci U S A., (19950000), vol. 92, pages 10292 - 10296, XP002007033 | |
| OPPOSITION | - WANG T-F, GUIDOTTI G, "CD39 IS AN ECTO-(CA2+,MG2+)-APYRASE", Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, US, US, (19960426), vol. 271, no. 17, doi:10.1074/jbc.271.17.9898, ISSN 0021-9258, pages 9898 - 9901, XP002928135 | |
| OPPOSITION | - KACZMAREK E, ET AL., "IDENTIFICATION AND CHARACTERIZATION OF CD39/VASCULAR ATP DIPHOSPHOHYDROLASE", Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, US, US, (19961220), vol. 271, no. 51, doi:10.1074/jbc.271.51.33116, ISSN 0021-9258, pages 33116 - 33122, XP002934573 | |
| OPPOSITION | - S PATOLA, B. N. et al., "Fully human anti-CD39 antibody potently inhibits ATPase activity in cancer cells via uncompetitive allosteric mechanism", MABS, (20200101), vol. 12, no. 1, page e1838036, XP055825366 | |
| OPPOSITION | - Deaglio Silvia, Dwyer Karen M., Gao Wenda, Friedman David, Usheva Anny, Erat Anna, Chen Jiang-Fan, Enjyoji Keiichii, Linden Joel, Oukka Mohamed, Kuchroo Vijay K., Strom Terry B., Robson Simon C., "Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression", JOURNAL OF EXPERIMENTAL MEDICINE, (20070600), vol. 204, no. 6, pages 1257 - 1265, XP002485581 | |
| OPPOSITION | - DEAGLIO SILVIA, ET AL, "Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression", Journal of Experimental Medicine, Rockefeller University Press, US, US, (20070601), vol. 204, no. 6, doi:10.1084/jem.20062512, ISSN 0022-1007, pages 1257 - 1265, XP002485581 | |
| OPPOSITION | - Shevach Ethan M., Dipaolo Richard A., Andersson John, Zhao Dong‐mei, Stephens Geoffrey L., Thornton Angela M., IMMUNOLOGICAL REVIEWS, (20060800), vol. 212, no. 1, pages 60 - 73, XP002485582 | |
| OPPOSITION | - SHEVACH ETHAN M, ET AL, "The lifestyle of naturally occurring CD4(+)CD25(+)Foxp3(+) regulatory T cells", Immunological Reviews, Wiley-Blackwell Publishing, Inc., US, US, (20060801), vol. 212, doi:10.1111/j.0105-2896.2006.00415.x, ISSN 0105-2896, pages 60 - 73, XP002485582 | |
| OPPOSITION | - Fecci Peter E., Sweeney Alison E., Grossi Peter M., Nair Smita K., Learn Christopher A., Mitchell Duane A., Cui Xiuyu, Cummings Thomas J., Bigner Darell D., Gilboa Eli, Sampson John H., "Systemic Anti-CD25 Monoclonal Antibody Administration Safely Enhances Immunity in Murine Glioma without Eliminating Regulatory T Cells", Clin Cancer Res, (20060715), vol. 12, no. 14, pages 4294 - 4305, XP055078141 | |
| OPPOSITION | - Authors' Affiliation: Department of Urology, University of Florida College of Medicine, Gainesville, Florida, "Reversal of Tumor-Mediated Immunosuppression", Clin Can Res, (20070115), vol. 13, no. 2, pages 727s - 732s, XP055940794 | |
| OPPOSITION | - Xian-Yang Li, Achim K. Moesta, Christos Xiao, Kyohei Nakamura, Mika Casey, Haiyan Zhang, Jason Madore, Ailin Lepletier, Amelia Roman Aguilera, Ashmitha Sundarrajan, Celia Jacoberger-Foissac, Clifford Wong, Tracy Dela Cruz, Megan Welch, Alana G. Lerner, Bradley N. Spatola, Vanessa B. Soros, John Corbin, Ana C. Anderson, Maike Effern, Michael Hölzel, Simon C. Robson, Rebecca L. Johnston, Nicola Waddell, Corey Smith, Tobias Bald, Nishamol Geetha, Courtney Beers, Michele W. L. Teng, Mark J. Smyth, "Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity", CANCER DISCOVERY, American Association for Cancer Research, US, US, (20191201), vol. 9, no. 12, doi:10.1158/2159-8290.CD-19-0541, ISSN 2159-8274, pages 1754 - 1773, XP055700762 | |
| OPPOSITION | - MARCUS AARON J ET AL, "The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.", The Journal of Clinical Investigation, B M J Group, GB, GB, (19970101), vol. 99, no. 6, doi:10.1172/JCI119294, ISSN 0021-9738, pages 1351 - 1360, XP002136366 | |
| OPPOSITION | - Curiel Tyler J., "Tregs and rethinking cancer immunotherapy", The Journal of Clinical Investigation, (20070500), vol. 117, no. 5, pages 1167 - 1174, XP055325100 | |
| OPPOSITION | - Tyler J. Curiel, "Tregs and rethinking cancer immunotherapy", The Journal of Clinical Investigations, (20070501), vol. 117, no. 5, doi:10.1172/JCI31202, pages 1167 - 1174, XP055325100 | |
| OPPOSITION | - BEYER, M. et al., "Regulatory T cells in cancer", Blood, (20060000), vol. 108, no. 3, doi:10.1182/blood-2006-02-002774, pages 804 - 11, XP055308928 | |
| OPPOSITION | - M. Beyer, Joachim L Schultze, "Regulatory T cells in cancer", Blood, (20060801), vol. 108, no. 3, pages 804 - 811, XP002549092 | |
| OPPOSITION | - BORSELLINO, G. et al., "Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression", Blood, (20070815), vol. 110, no. 4, pages 1225 - 1232, XP055791924 | |
| OPPOSITION | - Borsellino Giovanna, Kleinewietfeld Markus, Di Mitri Diletta, Sternjak Alexander, Diamantini Adamo, Giometto Raffaella, Höpner Sabine, Centonze Diego, Bernardi Giorgio, Dell'acqua Maria Luisa, Rossini Paolo Maria, Battistini Luca, Rötzschke Olaf, Falk Kirsten, "Abstract", Blood, American Society of Hematology, US, US, (20070815), vol. 110, no. 4, doi:10.1182/blood-2006-12-064527, ISSN 0006-4971, pages 1225 - 1232, XP055791924 | |
| OPPOSITION | - Borsellino Giovanna; Kleinewietfeld Markus; Di Mitri Diletta; Sternjak Alexander; Diamantini Adamo; Giometto Raffaella; Höpner Sabine; Centonze Diego; Bernardi Giorgio; Dell'acqua Maria Luisa; Rossini Paolo Maria; Battistini Luca; Rötzschke Olaf; Falk Kirsten, "Expression of ectonucleotidase CD 39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune sup- pression", Blood, (20070000), vol. 110, no. 4, pages 1225 - 1232, XP055791924 | |
| OPPOSITION | - Borsellino Giovanna, Kleinewietfeld Markus, Di Mitri Diletta, Sternjak Alexander, Diamantini Adamo, Giometto Raffaella, Höpner Sabine, Centonze Diego, Bernardi Giorgio, Dell'acqua Maria Luisa, Rossini Paolo Maria, Battistini Luca, Rötzschke Olaf, Falk Kirsten, "Expression of ectonucleotidase CD 39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression", Blood, (20070000), vol. 110, pages 1225 - 1232, XP055791924 | |
| OPPOSITION | - Szczepanski Miroslaw J; Szajnik Marta; Czystowska Malgorzata; Mandapathil Magis; Welsh Ann; Foon Kenneth; Whiteside Theresa L; Boyiadzis Michael, "Mechanisms of Suppression Used by Regulatory T Cells in Patients Newly Diagnosed with Acute Myeloid Leukemia", Blood, American Society of Hematology, US, US, (20081116), vol. 112, no. 11, doi:10.1182/blood.V112.11.2938.2938, ISSN 0006-4971, page 2938, XP086682235 | |
| OPPOSITION | - PULTE et al., "CD 39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia", Journal of Translational Medicine, (20070000), vol. 5, no. 23, doi:10.1186/1479-5876-5-23, pages 1 - 10, XP021030169 | |
| OPPOSITION | - Jackson Shaun W., Hoshi Tomokazu, Wu Yan, Sun Xiaofeng, Enjyoji Keiichi, Cszimadia Eva, Sundberg Christian, Robson Simon C., "Disordered Purinergic Signaling Inhibits Pathological Angiogenesis in Cd39/Entpd1-Null Mice", AMERICAN JOURNAL OF PATHOLOGY., Elsevier Inc., US, US, (20071001), vol. 171, no. 4, doi:10.2353/ajpath.2007.070190, ISSN 0002-9440, pages 1395 - 1404, XP055825362 | |
| OPPOSITION | - Jackson Shaun W; Hoshi Tomokazu; Wu Yan; Sun Xiaofeng; Enjyoji Keiichi; Cszimadia Eva; Sundberg Christian; Robson Simon C, "Disordered purinergic signaling inhibits pathological angiogenesis in cd 39/Entpdl-null mice", Am J Pathol., (20070000), vol. 171, no. 4, pages 1395 - 1404, XP055825362 | |
| OPPOSITION | - DAVID W HOSKIN et al., "Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review)", International Journal of Oncology, (20080000), vol. 32, pages 527 - 535, XP055574827 | |
| OPPOSITION | - David W Hoskin, Jamie S. Mader, Suzanne J. Furlong, David M. Conrad And Jonathan Blay, "Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review)", International journal of oncology, Demetrios A. Spandidos Ed. & Pub, GR, GR, (20080101), vol. 32, doi:10.3892/ijo.32.3.527, ISSN 1019-6439, pages 527 - 535, XP055574827 | |
| OPPOSITION | - Kobie James J., Shah Pranav R., Yang Li, Rebhahn Jonathan A., Fowell Deborah J., Mosmann Tim R., "T Regulatory and Primed Uncommitted CD4 T Cells Express CD73, Which Suppresses Effector CD4 T Cells by Converting 5′-Adenosine Monophosphate to Adenosine", The Journal of Immunology, Williams & Wilkins Co., US, US, (20061115), vol. 177, no. 10, doi:10.4049/jimmunol.177.10.6780, ISSN 0022-1767, pages 6780 - 6786, XP055794879 | |
| OTHER | - SFM Hausler, A.Honig, JB Engel, M Krockenberger, J Wischhusen, J Dietl, "CD39 wird von humanen Ovarialkarzinomzelllinien exprimiert und hemmt die immunologische Tumorabwehr /Abstract/", Thieme E-Journals- Geburtshilfe Frauenheilkunde, vol. 68, (20080000), URL: https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0028-1089305, XP055593991 | - |
| OTHER | - HOSKIN et al., "Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review)", International Journal of Oncology, (20080000), vol. 32, pages 527 - 535, XP055574827 | |
| SEARCH | - SCHETINGER MARIA ROSA C ET AL, "NTPDase and 5 '-nucleotidase activities in physiological and disease conditions: New perspectives for human health", BIOFACTORS, (2007), vol. 31, no. 2, ISSN 0951-6433, pages 77 - 98, XP009116149 [A] 1-3 * page 84 - page 87 * | |
| SEARCH | - DWYER ET AL., "CD39 and control of cellular immune responses", PURINERGIC SIGNALLING, (20070206), vol. 3, pages 171 - 180, XP002485580 [A] 1-3 * the whole document * | |
| SEARCH | - M�LLER SINA ET AL, "Monitoring the expression of purinoceptors and nucleotide-metabolizing ecto-enzymes with antibodies directed against proteins in native conformation.", PURINERGIC SIGNALLING SEP 2007, (200709), vol. 3, no. 4, ISSN 1573-9538, pages 359 - 366, XP019558228 [A] 1-3 * the whole document * | |
| SEARCH | - DEAGLIO SILVIA ET AL, "Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression", JOURNAL OF EXPERIMENTAL MEDICINE, (200706), vol. 204, no. 6, ISSN 0022-1007, pages 1257 - 1265, XP002485581 [A] 1-3 * the whole document * | |
| SEARCH | - SHEVACH ETHAN M ET AL, "The lifestyle of naturally occurring CD4(+)CD25(+)Foxp3(+) regulatory T cells", IMMUNOLOGICAL REVIEWS, (200608), vol. 212, ISSN 0105-2896, pages 60 - 73, XP002485582 [A] 1-3 * the whole document * | |
